Want to see HK:2563 full AI Analyst Report?
Beijing Biostar Pharmaceuticals Co., Ltd. Class H (2563) Financial Statements
0 Followers
Beijing Biostar Pharmaceuticals Co., Ltd. Class H Financial Overview
Beijing Biostar Pharmaceuticals Co., Ltd. Class H's market cap is currently HK$1.36B. The company's EPS TTM is HK$-0.34; its P/E ratio is -10.19; Beijing Biostar Pharmaceuticals Co., Ltd. Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Jun 25 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 37.12M | HK$ 77.92M | HK$ 73.75M | HK$ 37.38M | HK$ 106.74M |
| Gross Profit | HK$ 33.65M | HK$ 66.75M | HK$ 51.83M | HK$ 27.20M | HK$ 100.48M |
| Operating Income | HK$ -151.39M | HK$ -184.38M | HK$ -241.26M | HK$ -227.94M | HK$ -411.45M |
| EBITDA | HK$ -139.77M | HK$ -173.84M | HK$ -198.08M | HK$ -170.77M | HK$ -430.65M |
| Net Income | HK$ -142.54M | HK$ -155.89M | HK$ -209.90M | HK$ -182.81M | HK$ -417.79M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 508.15M | HK$ 609.16M | HK$ 637.54M | HK$ 830.57M | HK$ 988.06M |
| Total Assets | HK$ 861.37M | HK$ 971.51M | HK$ 854.83M | HK$ 1.06B | HK$ 1.45B |
| Total Debt | HK$ 2.20M | HK$ 1.26M | HK$ 995.01K | HK$ 2.17M | HK$ 1.72M |
| Net Debt | HK$ -505.96M | HK$ -495.15M | HK$ -41.16M | HK$ -66.29M | HK$ -401.47M |
| Total Liabilities | HK$ 120.36M | HK$ 130.31M | HK$ 54.44M | HK$ 66.53M | HK$ 30.34M |
| Stockholders' Equity | HK$ 741.01M | HK$ 841.20M | HK$ 800.40M | HK$ 988.49M | HK$ 1.42B |
| Cash Flow | |||||
| Free Cash Flow | HK$ -174.59M | HK$ -163.18M | HK$ -197.69M | HK$ -127.69M | HK$ -134.93M |
| Operating Cash Flow | HK$ -168.56M | HK$ -119.77M | HK$ -166.88M | HK$ -90.47M | HK$ -118.32M |
| Investing Cash Flow | HK$ 99.59M | HK$ 56.88M | HK$ 145.30M | HK$ -167.18M | HK$ 192.93M |
| Financing Cash Flow | HK$ -1.39M | HK$ 221.38M | HK$ -1.25M | HK$ 4.02M | HK$ -1.21M |
Currency in HKD
